Zdenka Jerala

Title: Zdenka Jerala: Innovator in Pharmaceutical Formulations

Introduction

Zdenka Jerala is a notable inventor based in Mavcice, Slovenia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid formulations for cholesterol-lowering medications. With a total of 2 patents, her work has the potential to impact the treatment of hypercholesterolemia and hyperlipidemia.

Latest Patents

Zdenka Jerala's latest patents include a novel solid pharmaceutical formulation containing lovastatin and simvastatin. This formulation features a particle size D(0.9) between 15 and 100 µm and a specific particle surface area between 1 and 4 m/g. The invention also encompasses the process for preparing this formulation, as well as the method for producing lovastatin and simvastatin with crystal sizes suitable for the pharmaceutical formulation. This innovative formulation is particularly useful for treating conditions related to high cholesterol and lipid levels.

Career Highlights

Zdenka Jerala is associated with Lek Pharmaceuticals D.d., where she has been instrumental in advancing pharmaceutical research and development. Her expertise in solid pharmaceutical formulations has positioned her as a key player in the industry.

Collaborations

Zdenka has collaborated with notable colleagues, including Zlatko Pflaum and Mateja Salobir, who have contributed to her research endeavors. Their teamwork has fostered an environment of innovation and excellence in pharmaceutical development.

Conclusion

Zdenka Jerala's contributions to pharmaceutical formulations demonstrate her commitment to improving health outcomes through innovative solutions. Her patents reflect a deep understanding of the complexities involved in drug formulation, making her a valuable asset to the field.